MiR-1827 is also reported to be a tumor suppressor by regulating P53 (45) and miR-106b, and is a potent biomarker for gastric cancer, hepatocellular carcinoma, chronic hepatic disease, and cutaneous melanoma (46, 47). Here, TP53 is linked to gastric cancer.